Belvedere Trading
SLDB icon

Belvedere Trading’s Solid Biosciences SLDB Stock Holding History

Belvedere Trading’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-901
Closed -$3.6K – 966
2024
Q4 		$3.6K Buy
+901
New +$4.95K ﹤0.01% 766

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Belvedere Trading's SLDB Position: Q1 2025 in Review

Belvedere Trading sold out of Solid Biosciences (SLDB) in Q1 2025, closing a stake of 901 shares — an estimated $3.6K sold.

Belvedere Trading first reported a position in SLDB in Q4 2024 and held it in 1 quarter. The position peaked at $3.6K in Q4 2024. 124 funds tracked by Wall St. Rank hold SLDB as of Q1 2025.

  • Belvedere Trading reported no remaining Solid Biosciences position as of Q1 2025 after selling out during the quarter.
  • Belvedere Trading sold 901 Solid Biosciences shares in Q1 2025, an estimated $3.6K.
  • Belvedere Trading first reported a position in Solid Biosciences in Q4 2024 and held it in 1 quarter.
  • Belvedere Trading's Solid Biosciences position peaked at $3.6K in Q4 2024.
  • 124 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2025.

Based on Belvedere Trading's 13F filing for Q1 2025, filed 9 May 2025.